An Edmonton startup boasting the world’s largest online pharmaceutical knowledge database had its humble beginnings inside a University of Alberta lab.
(0)
TORONTO and CAMBRIDGE, Mass., May 12, 2021 (GLOBE NEWSWIRE) ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Rudolph Tanzi, Ph.D, as Chair of the Company s scientific advisory board (SAB). Dr. Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Co-Director of the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital.
Date Time
Fast-growing Edmonton startup helps get new drugs to market sooner
An Edmonton startup has become the world’s largest pharmaceutical knowledge database, through research that began at the University of Alberta.
DrugBank offers a one-stop shop for curated scientific data on thousands of drugs, including molecular details, chemical structures, targets and proteins, as well as clinical information on side-effects, interactions with other drugs, allergies, synonym names, availability and more. The company already has more than 20,000 drugs in its database, with a focus on approved drugs or those in clinical trials.
In just five years, the startup has become one of the fastest-growing in Edmonton, going from two employees in 2016 to a current count of 43. Revenue has increased 300 per cent and despite the uncertainty created by the COVID-19 pandemic DrugBank’s fundraising round last year ended 20 per cent above target, with financial support from venture capitalists and
Share
DrugBank founders Craig Knox (left) and Michael Wilson say the innovative idea behind their fast-growing company, which provides the world’s largest database of pharmaceutical information, started out as an undergraduate research project at the U of A. (Photo: Supplied)
An Edmonton startup has become the world’s largest pharmaceutical knowledge database, through research that began at the University of Alberta.
DrugBank offers a one-stop shop for curated scientific data on thousands of drugs, including molecular details, chemical structures, targets and proteins, as well as clinical information on side-effects, interactions with other drugs, allergies, synonym names, availability and more. The company already has more than 20,000 drugs in its database, with a focus on approved drugs or those in clinical trials.
ProMIS Neurosciences Announces Fiscal Year 2020 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.